Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Mon, 13.07.2026
Evotec SE
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Hamburg, Germany – Evotec SE (NASDAQ: EVO; Frankfurt Prime Standard: EVT) today announced preliminary unaudited financial results for the s [ … ]
Mon, 13.07.2026
Gateway Real Estate AG
Gateway Real Estate AG: Forecast for the financial year 2026
Berlin, July 13, 2026. The Management Board and Supervisory Board of Gateway Real Estate AG (“Company” - WKN A0JJTG / ISIN DE000A0JJTG7) have adopted the forecast for the financial year 2026 at their meeting today.
For the current year 2026 the Company expects as consolidated result EBI [ … ]
Mon, 13.07.2026
Drägerwerk AG & Co. KGaA
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Preliminary figures H1 2026: Net sales strongly up, earnings significantly above the prior year – positive earnings outlook
Lübeck, July 13, 2026 – Based on preliminary calculations, Dräger’s net sales rose by 7.7 percent (net of currency effects; nominal: 6.2 [ … ]
Mon, 13.07.2026
J.P. Morgan SE
13 July 2026
Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.
OHB SE
Announcement: Stabilization Manager undertakes stabilisation measure[s]
J.P. Morgan SE (contact: Stefan Weiner; telephone: +49 (0) 6971240) hereby gives notice, as Stabilisa [ … ]
Mon, 13.07.2026
Vossloh Aktiengesellschaft
Vossloh Aktiengesellschaft: Adjustment of Sales Revenues and Earnings Guidance for Fiscal Year 2026[DG1]
Today, based on the latest insights regarding business performance, the Executive Board of Vossloh Aktiengesellschaft has adjusted its guidance for fiscal year 2026.
Based on preliminary figures, Vossloh generated sales revenues of €710.1 mill [ … ]
Mon, 13.07.2026
Mesabi Metallics Co. LLC
Mesabi Metallics fires first blast toward "Patriot Pellet," ending U.S. dependence on scarce foreign DR-grade ore
NASHWAUK, Minn., July 13, 2026 /PRNewswire/ -- American iron ore mining is growing. Mesabi Metallics Company LLC (Mesabi Metallics) today announced the successful completion of its first production blast, a defining milestone in the com [ … ]
Mon, 13.07.2026
Leifheit Aktiengesellschaft
Leifheit Aktiengesellschaft: Leifheit approves the execution of the FOCUS performance program to sustainably improve profitability and adjusts its forecast for FY 2026
Execution of the FOCUS performance program will result in annual cost savings of approx. EUR 7.5 million starting in 2028
The measures result in special items totaling up to EUR 9. [ … ]
Mon, 13.07.2026
Private Equity Holding AG
NEWS RELEASE
Zurich, July 13, 2026
Net Asset Value as of June 30, 2026
As of June 30, 2026, the Net Asset Value (NAV) per share of Private Equity Holding AG (PEH) stood at EUR 158.65 (CHF 146.42), representing a change of 1.2% in EUR (2.3% in CHF) since May 31, 2026.
PEH's portfolio performance was positive in June, mainly driven by favourable [ … ]
Mon, 13.07.2026
Shelly Group SE
Publication of inside information according to Article 17 MARShelly Group reports preliminary group revenue for the first half of 2026
Sofia / Munich, 13 July 2026 – Shelly Group SE (Ticker: SLYG / ISIN: BG1100003166) (“Shelly Group” / “the Company”) reported a year-on-year increase in revenue from Shelly devices and related services of approx. 27% [ … ]
Mon, 13.07.2026
Northwest Biotherapeutics Inc.
Company Name:
Northwest Biotherapeutics Inc.
ISIN:
US66737P6007
Reason for the research:
Update
Recommendation:
Buy
from:
13.07.2026
Target price:
USD 1.00
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Christian Orquera
First Berlin Equity Research has published a research update on Northwest Biotherapeuti [ … ]
